BENJAMIN LEVINE EBERT

City:

BOSTON, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2022-08-11

Top Assignees for applications by BENJAMIN LEVINE EBERT

The entities that hold a legal rights for patent applications filed by inventor EBERT BENJAMIN LEVINE:

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 8 Boston, MA United States
THE BROAD INSTITUTE, INC. 7 Cambridge, MA United States
President and Fellows of Harvard College 2 Cambridge, MA United States
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 1 Cambridge, MA United States
Dana-Farber-Cancer Institute, Inc. 1 Boston, MA United States
The Brigham & Women's Hospital, Inc. 1 Boston, MA United States
BRIGHAM AND WOMEN'S HOSPITAL, INC. 1 Boston, MA United States

Recent patent applications by EBERT BENJAMIN LEVINE

BENJAMIN LEVINE EBERT from BOSTON, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-08-11

US20220251651A1

Chemistry; metallurgy

Methods of characterizing resistance to modulators of Cereblon

#2 | 2022-01-20

US20220017938A1

Chemistry; metallurgy

METHODS OF IDENTIFYING DRUG-MODULATED POLYPEPTIDE TARGETS FOR DEGRADATION

#3 | 2019-09-12

US20190274292A1

Human necessities

Disease biomarkers and treatment methods related thereto

#4 | 2019-04-11

US20190106710A1

Chemistry; metallurgy

Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions

#5 | 2019-03-07

US20190071731A1

Chemistry; metallurgy

Methods of identifying a polypeptide target for degradation by a modulator of CRBN

#6 | 2018-12-06

US20180343839A1

Human necessities

IMiD screening methods IMiD-sensitive cells with mutant CRBN

#7 | 2016-11-24

US20160338326A1

Human necessities

Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof

#8 | 2016-09-29

US20160282354A1

Physics

COMPOSITIONS AND METHODS FOR SELECTING A TREATMENT FOR B-CELL NEOPLASIAS

#9 | 2014-05-08

US20140127690A1

Chemistry; metallurgy

Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects

InventorID:

1664250 ⎘